NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor Therapeutics, Inc. (Headquarters: California, ...

NS Pharma, a subsidiary of Nippon Shinyaku Co., announced that acceptance has been received by Capricor Therapeutics (CAPR) from the U.S. FDA ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases.

PARAMUS, N.J., March 10, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd ... an investigational cell therapy, as a treatment for patients diagnosed ...

The Nippon India Large Cap Fund - Growth has an AUM of 35667.30 crores & has delivered CAGR of 21.52% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.57%.

Nippon Steel Vice Chairperson Takahiro Mori left Japan for the United States on Wednesday to lay the groundwork for talks between the Japanese company and the administration of U.S. President ...

TOKYO : Japan's largest private life insurer, Nippon Life Insurance, has bought more foreign bonds since October and may keep buying them this year, given the impact of U.S. President Donald Trump ...

A vivid new image is taking shape in the world of cell biology: Imagine bacteria adhering to the surface of a cell, perhaps at the site of an injury or wound. In response, a white blood cell ...

U.S. President Donald Trump on Friday railed against what he called tremendously high Canadian tariffs on dairy and lumber, and said his administration could soon impose reciprocal tariffs on ...

Identifying and delineating cell structures in microscopy images is crucial for understanding the complex processes of life. This task is called "segmentation" and it enables a range of ...